No trading action is suggested based on this filing. Monitor future Form 4 filings for actual option exercises or sales, which could signal insider sentiment. The Power of Attorney simplifies compliance but does not imply imminent transactions.
Price Chart
Executive Summary
Frank Witney, a reporting person at Alamar Biosciences, filed a Form 3 to report initial beneficial ownership of stock options to purchase Class B Common Stock. The filing includes a Power of Attorney authorizing company executives to file SEC Forms 3, 4, and 5 on his behalf. This is a routine initial ownership disclosure with no immediate financial impact.
Key Facts
- Frank Witney filed a Form 3 to report initial ownership of stock options in Alamar Biosciences, Inc. (ALMR).
- The options include: 124,069 shares at $7.60 strike price (vesting starts 1/15/2027), 49,627 shares at $0.59 (fully vested), and 33,085 shares at $3.10 (vesting monthly from 1/1/2025).
- A Power of Attorney was granted to Timothy White, Justin J. McAnear, Mike Seater, and Jessie Wang to file Section 16 reports on Witney’s behalf.
- The filing is administrative and does not indicate any change in ownership or transaction activity.
Financial Impact
No immediate financial impact — this is a disclosure of existing or newly granted options, not an exercise or sale.
Risk Factors
- Potential future dilution if the reported stock options are exercised, though magnitude is currently small and spread over time.
- Lack of disclosed ownership percentage or total holdings limits assessment of insider concentration risk.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001455312-26-000002 |
| Document: 0001455312-26-000002-index-headers.html | 0001455312-26-000002 |
| Document: 0001455312-26-000002-index.html | 0001455312-26-000002 |
| Document: 0001455312-26-000002.txt | 0001455312-26-000002 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 11d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (−10.83%) |
Oct 14, 2026 11d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (−10.83%) |
Oct 14, 2026 11d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (+10.83%) |
Oct 5, 2026 21d ago | Press Release | $32.26 | awaiting T+60 | — | $30.39 (−5.80%) |
Sep 24, 2026 4w ago | Press Release | $32.80 | awaiting T+60 | — | $30.39 (−7.35%) |
Sep 1, 2026 7w ago | 8-K | $30.49 | awaiting T+60 | — | $30.39 (−0.33%) |
Aug 10, 2026 11w ago | 8-K | $36.57 | awaiting T+60 | — | $30.39 (−16.90%) |
Jul 13, 2026 15w ago | Press Release | $27.40 $32.26 | ▲ +17.74% | ▲ +13.74% | $30.39 (+10.91%) |
Jul 10, 2026 15w ago | Press Release | $28.42 $38.13 | ▲ +34.17% | ▲ +31.53% | $30.39 (+6.93%) |
May 8, 2026 24w ago | 8-K | $23.96 $27.11 | ▲ +13.15% | ▲ +8.31% | $30.39 (+26.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers